{"id":46,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=46"},"modified":"2026-05-16T14:06:28","modified_gmt":"2026-05-16T12:06:28","slug":"retatrutid","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/sv\/shop\/retatrutide\/","title":{"rendered":"Retatrutid"},"content":{"rendered":"

Retatrutide - multireceptorpeptid f\u00f6r metabolisk behandling och viktkontroll<\/strong><\/p>\n

Sammans\u00e4ttning: <\/strong>Retatrutid (frystorkat peptidpulver)
Kategori:<\/strong> Peptid
Form:<\/strong> Flaska med frystorkat pulver
Administration:<\/strong> Subkutan injektion efter rekonstitution med bakteriostatiskt vatten<\/p>\n

\n

Vad \u00e4r Retatrutide?<\/h3>\n

Retatrutid \u00e4r en avancerad, l\u00e5ngverkande peptid med trippel agonist<\/strong> som samtidigt aktiverar GLP-1 (glukagonliknande peptid-1)<\/strong>, GIP (glukosberoende insulinotropisk polypeptid)<\/strong>, och Glukagonreceptorer<\/strong>.
Den tillh\u00f6r en ny generation av peptider f\u00f6r metabolisk forskning<\/strong> utformad f\u00f6r att \u00f6ka energif\u00f6rbrukningen<\/strong>, reglera aptiten<\/strong>, och f\u00f6rb\u00e4ttra glukos- och lipidmetabolismen<\/strong>.<\/p>\n

Genom samtidig aktivering av flera metaboliska v\u00e4gar har retatrutid visat en anm\u00e4rkningsv\u00e4rd potential i prekliniska och kliniska studier<\/strong> utredande fetma, insulinresistens,<\/strong> och metaboliska st\u00f6rningar<\/strong>.<\/p>\n

\u27a1\ufe0f Idealisk f\u00f6r energibalans, viktreglering,<\/strong> och peptidbaserad metabolisk modulering.<\/strong><\/p>\n

\n

Viktiga forskningsresultat<\/h3>\n

Trippel receptoraktivering:<\/strong> Simultan stimulering av GLP-1, GIP,<\/strong> och Glukagonreceptorer<\/strong> f\u00f6r \u00f6kad metabolisk effektivitet.<\/p>\n

Reglering av aptit och energi:<\/strong> P\u00e5verkar centrala mekanismer i aptitkontroll<\/strong> och fr\u00e4mjar kalorif\u00f6rbrukning<\/strong>.<\/p>\n

Glukos- och lipidmetabolism:<\/strong> St\u00f6der f\u00f6rb\u00e4ttrad Insulink\u00e4nslighet, glukoshomeostas,<\/strong> och fettoxidation<\/strong>.<\/p>\n

Kroppssammans\u00e4ttning:<\/strong> Studerades f\u00f6r sin potential att minska kroppsfett<\/strong> medan bevara mager massa<\/strong>.<\/p>\n

\n

Dosering och anv\u00e4ndning<\/h3>\n

\u00c5terst\u00e4ll med bakteriostatiskt vatten<\/strong> f\u00f6re anv\u00e4ndning.<\/p>\n

Typiskt forskningsomr\u00e5de: 0,25-1,0 mg per applicering<\/strong>, subkutant (beroende p\u00e5 studiedesign).<\/p>\n

Frekvens: Variabel, ofta 1-2 g\u00e5nger per vecka<\/strong> i l\u00e5ngsiktiga metaboliska studier.<\/p>\n

F\u00f6rvara den rekonstituerade l\u00f6sningen kyld<\/strong> och anv\u00e4ndning inom 30 dagar<\/strong>.<\/p>\n

\n

Instruktioner f\u00f6r f\u00f6rvaring<\/h3>\n
    \n
  • \n

    Butik p\u00e5 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Skydda fr\u00e5n ljus och fukt<\/strong><\/p>\n<\/li>\n

  • \n

    F\u00e5r inte frysas<\/strong><\/p>\n<\/li>\n

  • \n

    Undvik temperaturfluktuationer<\/p>\n<\/li>\n<\/ul>\n

    \n

    Varf\u00f6r v\u00e4lja Retatrutide?<\/h3>\n

    Retatrutid \u00e4r en av de mest de mest avancerade peptiderna med flera agonister<\/strong> f\u00f6r n\u00e4rvarande under utredning.
    Genom sin synergistisk aktivering av GLP-1-, GIP- och glukagonreceptorer<\/strong>, ger den en unik inblick i hur hormonell reglering av energibalans, fettmetabolism och aptitkontroll<\/strong>.<\/p>\n

    Best\u00e4ll Retatrutide <\/strong>\u00a0och utforska dess potential i n\u00e4sta generation av forskning om \u00e4mnesoms\u00e4ttning och viktkontroll.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Retatrutide \u2013 Multi-Receptor Peptide for Metabolic & Weight Management Composition: Retatrutide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Retatrutide? Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors.It belongs to a new generation of metabolic research peptides designed to increase energy expenditure, regulate appetite, and improve glucose and lipid metabolism. Through the simultaneous activation of multiple metabolic pathways, Retatrutide has shown remarkable potential in preclinical and clinical studies investigating obesity, insulin resistance, and metabolic disorders. \u27a1\ufe0f Ideal for energy balance, weight regulation, and peptide-based metabolic modulation. Key Research Findings Triple Receptor Activation: Simultaneous stimulation of GLP-1, GIP, and Glucagon receptors for enhanced metabolic efficiency. Appetite & Energy Regulation: Influences central mechanisms of appetite control and promotes caloric expenditure. Glucose & Lipid Metabolism: Supports improved insulin sensitivity, glucose homeostasis, and fat oxidation. Body Composition: Studied for its potential to reduce body fat while preserving lean mass. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously (depending on study design). Frequency: Variable, often 1\u20132 times per week in long-term metabolic studies. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Retatrutide? Retatrutide is one of the most advanced multi-agonist peptides currently under investigation.Through its synergistic activation of GLP-1, GIP, and Glucagon receptors, it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control. Order Retatrutide \u00a0and explore its potential in the next generation of metabolic and weight management research.<\/p>","protected":false},"featured_media":59,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":{"0":"post-46","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-all-products","7":"product_cat-glp-1andmultiagonist","8":"product_cat-metabolismandweightmanagement","9":"product_cat-peptidesandresearchdrugs","10":"entry","11":"has-media","13":"first","14":"instock","15":"sale","16":"purchasable","17":"product-type-variable"},"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product\/46","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/comments?post=46"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product\/46\/revisions"}],"predecessor-version":[{"id":28952,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product\/46\/revisions\/28952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/media\/59"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/media?parent=46"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product_brand?post=46"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product_cat?post=46"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product_tag?post=46"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}